Ligand id: 8711

Name: tesidolumab

Compound class Antibody
International Nonproprietary Names
INN number INN
10051 tesidolumab
LFG-316 | LFG316
Tesidolumab is a fully human monoclonal antibody targeting complement C5. Like eculizumab, this investigational monoclonal inhibits terminal complement activation.
Peptide sequence and secondary structural information for this antibody are available from its IMGT/mAb-DB record.
Peptide sequence alignment analysis using the heavy and light variable domains of tesidolumab provide 100% matches to SEQ ID NOs 7 and 8 respectively from patent US8241628 [1]. These peptide sequences correspond to antibody (MOR0)8109 in said patent.
Database Links
Specialist databases
IMGT/mAb-DB 535
Other databases
GtoPdb PubChem SID 252827369
Search PubMed clinical trials tesidolumab
Search PubMed titles tesidolumab
Search PubMed titles/abstracts tesidolumab